Secondary Sjögren's syndrome in systemic lupus erythematosus defines a distinct disease subset

Journal of Rheumatology

Volumn 37, Issue 6, 2010, Pages 1143-1149

  Baer, Alan N ^a   Maynard, Janet W ^a   Shaikh, Fasil ^a   Magder, Laurence S ^b   Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Sj gren's syndrome; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY;

ADULT; AGE DISTRIBUTION; ARTHRITIS; ARTICLE; DISCOID RASH; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HEMATURIA; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALAR RASH; MALE; MOUTH ULCER; NEPHROTIC SYNDROME; PERICARDITIS; PHENOTYPE; PHOTOSENSITIVITY; PLEURISY; PRIORITY JOURNAL; PROTEINURIA; PSYCHOSIS; RASH; RAYNAUD PHENOMENON; RISK ASSESSMENT; SALIVARY GLAND BIOPSY; SEIZURE; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; COHORT ANALYSIS; COMORBIDITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; STATISTICAL MODEL; UNITED STATES;

ADULT; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MARYLAND; MULTIVARIATE ANALYSIS; SJOGREN'S SYNDROME;

EID: 77953195316     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090804     Document Type: Article

References (34)

1. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558
2. Provost TT. Anti-Ro(SSA) and anti-La(SSB) antibodies in lupus erythematosus and Sjogren's syndrome. Keio J Med 1991;40:72-77
3. Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE. Primary Sjogren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986;104:323-330 (Pubitemid 16163608)
4. Pease CT, Shattles W, Barrett NK, Maini RN. The arthropathy of Sjogren's syndrome. Br J Rheumatol 1993;32:609-613
5. Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, et al. Sjogren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren's syndrome. Arthritis Rheum 2004;50:882-891
6. Pan HF, Ye DQ, Wang Q, Li WX, Zhang N, Li XP, et al. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjogren syndrome in China: a study of 542 patients. Clin Rheumatol 2008;27:339-343
7. Nossent JC, Swaak AJ. Systemic lupus erythematosus VII: frequency and impact of secondary Sjogren's syndrome. Lupus 1998;7:231-234
8. Jonsson H, Nived O, Sturfelt G, Norberg R. Symptomatic secondary Sjögren's syndrome in patients with systemic lupus erythematosus (SLE). Relation to anti-SS-A and anti-SS-B autoantibodies. Scand J Rheumatol Suppl 1986;61:166-169 (Pubitemid 17120353)
9. Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M. Clinical, serologic, and genetic profiles of patients with associated Sjogren's syndrome and systemic lupus erythematosus. Hum Immunol 2006;67:924-930
10. Xu D, Tian X, Zhang W, Zhang X, Liu B, Zhang F. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: A case-control study. Lupus 2010;19:197-200.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-640
14. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-369
15. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjoegren's syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine 1965;44:187-231.
16. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology 2003;42:276-279
17. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000;43:1801-1808
18. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999;38:1130-1137 (Pubitemid 29537336)
19. Heaton JM. Sjogren's syndrome and systemic lupus erythematosus. Br Med J 1959;1:466-469
20. Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum 1986;29:196-206.
21. Alarcon-Segovia D, Ibanez G, Velazquez-Forero F, Hernandez-Ortiz J, Gonzalez-Jimenez Y. Sjogren's syndrome in systemic lupus erythematosus. Clinical and subclinical manifestations. Ann Intern Med 1974;81:577-583
22. Gilboe IM, Kvien TK, Uhlig T, Husby G. Sicca symptoms and secondary Sjogren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 2001;60:1103-1109
23. Moutsopoulos HM, Klippel JH, Pavlidis N, Wolf RO, Sweet JB, Steinberg AD, et al. Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. Arthritis Rheum 1980;23:36-40.
24. Provost TT, Talal N, Harley JB, Reichlin M, Alexander E. The relationship between anti-Ro (SS-A) antibody-positive Sjogren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Arch Dermatol 1988;124:63-71.
25. Schur PH, Stollar BD, Steinberg AD, Talal N. Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases. Arthritis Rheum 1971;14:342-347
26. Simmons-O'Brien E, Chen S, Watson R, Antoni C, Petri M, Hochberg M, et al. One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine 1995;74:109-130
27. Ramos-Casals M, Font J, Garcia-Carrasco M, Brito MP, Rosas J, Calvo-Alen J, et al. Primary Sjogren syndrome: hematologic atterns of disease expression. Medicine 2002;81:281-292
28. McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 2000;59:230-232
29. Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjogren's syndrome in systemic lupus erythematosus. J Rheumatol 1990;17:201-204 (Pubitemid 20108223)
30. Yu DF, Chen Y, Han JM, Zhang H, Chen XP, Zou WJ, et al. MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjogren syndrome patients. Exp Eye Res 2008;86:403-411
31. Hamilton RG, Harley JB, Bias WB, Roebber M, Reichlin M, Hochberg MC, et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988;31:496-505.
32. Wasicek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 1982;69:835-43.
33. Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 2004;83:348-59.
34. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005;52:4003-4010